Review



anti cd86 primary antibody  (Proteintech)


Bioz Verified Symbol Proteintech is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 96
      Buy from Supplier

    Structured Review

    Proteintech anti cd86 primary antibody
    ROS- s cavenging and a nti- i nflammatory p roperties of CVs. (A). CLSM images showing ROS green fluorescent levels in RAW264.7 cells with DCFH-DA probe. Scale bar, 50 μm. (B). Representative images of flow cytometry detecting ROS with various groups in RAW264.7 cells. (C). Quantitative analysis of the mean fluorescence intensity of ROS depicted in B. (n = 3, mean ± s.d.). (D). Representative images of flow cytometry detecting apoptosis rates of RAW264.7 cells in different groups. (E). Quantitative analysis of the MFI of apoptosis rates depicted in D. (n = 3, mean ± s.d.). (F). Representative immunofluorescence images of <t>CD86</t> in various groups. Scale bar, 50 μm. (G). Representative images of flow cytometry detecting CD86 with various groups in RAW264.7 cells. (H). Quantitative analysis of the MFI of CD86 depicted in G. (n = 3, mean ± s.d.). (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)
    Anti Cd86 Primary Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 420 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti cd86 primary antibody/product/Proteintech
    Average 96 stars, based on 420 article reviews
    anti cd86 primary antibody - by Bioz Stars, 2026-02
    96/100 stars

    Images

    1) Product Images from "Vitamin C–functionalized copper nanozymes for treating drug-resistant intracellular infections and hyperinflammation"

    Article Title: Vitamin C–functionalized copper nanozymes for treating drug-resistant intracellular infections and hyperinflammation

    Journal: Materials Today Bio

    doi: 10.1016/j.mtbio.2025.102348

    ROS- s cavenging and a nti- i nflammatory p roperties of CVs. (A). CLSM images showing ROS green fluorescent levels in RAW264.7 cells with DCFH-DA probe. Scale bar, 50 μm. (B). Representative images of flow cytometry detecting ROS with various groups in RAW264.7 cells. (C). Quantitative analysis of the mean fluorescence intensity of ROS depicted in B. (n = 3, mean ± s.d.). (D). Representative images of flow cytometry detecting apoptosis rates of RAW264.7 cells in different groups. (E). Quantitative analysis of the MFI of apoptosis rates depicted in D. (n = 3, mean ± s.d.). (F). Representative immunofluorescence images of CD86 in various groups. Scale bar, 50 μm. (G). Representative images of flow cytometry detecting CD86 with various groups in RAW264.7 cells. (H). Quantitative analysis of the MFI of CD86 depicted in G. (n = 3, mean ± s.d.). (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)
    Figure Legend Snippet: ROS- s cavenging and a nti- i nflammatory p roperties of CVs. (A). CLSM images showing ROS green fluorescent levels in RAW264.7 cells with DCFH-DA probe. Scale bar, 50 μm. (B). Representative images of flow cytometry detecting ROS with various groups in RAW264.7 cells. (C). Quantitative analysis of the mean fluorescence intensity of ROS depicted in B. (n = 3, mean ± s.d.). (D). Representative images of flow cytometry detecting apoptosis rates of RAW264.7 cells in different groups. (E). Quantitative analysis of the MFI of apoptosis rates depicted in D. (n = 3, mean ± s.d.). (F). Representative immunofluorescence images of CD86 in various groups. Scale bar, 50 μm. (G). Representative images of flow cytometry detecting CD86 with various groups in RAW264.7 cells. (H). Quantitative analysis of the MFI of CD86 depicted in G. (n = 3, mean ± s.d.). (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)

    Techniques Used: Flow Cytometry, Fluorescence, Immunofluorescence



    Similar Products

    primary antibodies against cd86  (Bioss)
    95
    Bioss primary antibodies against cd86
    Primary Antibodies Against Cd86, supplied by Bioss, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibodies against cd86/product/Bioss
    Average 95 stars, based on 1 article reviews
    primary antibodies against cd86 - by Bioz Stars, 2026-02
    95/100 stars
    		  Buy from Supplier
    mouse cd86 primary antibody  (Boster Bio)
    99
    Boster Bio mouse cd86 primary antibody
    The effects of patches on angiogenesis and inflammation in infarcted tissues 4 weeks post-MI. a) Immunofluorescence staining of α-smooth muscle actin (α-SMA, a vascular protein marker, green) and von Willebrand factor (vWF, an endothelial marker, red) of the infarct region in the MI, BMN-P, BMN-CP and CBMN-CP groups. b, c) Quantitative analysis of α-SMA (b) and vWF (c) in different groups based on fluorescent staining images (n = 4). d) Representative immunofluorescence staining of the infarct region in different groups for <t>CD86</t> (green) and CD206 (red). e, f) Fluorescence intensity statistics of CD86 (e) and CD206 (f) in different groups based on fluorescent staining images (n = 4). Nuclei are stained blue with DAPI. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001.
    Mouse Cd86 Primary Antibody, supplied by Boster Bio, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse cd86 primary antibody/product/Boster Bio
    Average 99 stars, based on 1 article reviews
    mouse cd86 primary antibody - by Bioz Stars, 2026-02
    99/100 stars
    		  Buy from Supplier
    anti cd86 primary antibody  (Proteintech)
    96
    Proteintech anti cd86 primary antibody
    ROS- s cavenging and a nti- i nflammatory p roperties of CVs. (A). CLSM images showing ROS green fluorescent levels in RAW264.7 cells with DCFH-DA probe. Scale bar, 50 μm. (B). Representative images of flow cytometry detecting ROS with various groups in RAW264.7 cells. (C). Quantitative analysis of the mean fluorescence intensity of ROS depicted in B. (n = 3, mean ± s.d.). (D). Representative images of flow cytometry detecting apoptosis rates of RAW264.7 cells in different groups. (E). Quantitative analysis of the MFI of apoptosis rates depicted in D. (n = 3, mean ± s.d.). (F). Representative immunofluorescence images of <t>CD86</t> in various groups. Scale bar, 50 μm. (G). Representative images of flow cytometry detecting CD86 with various groups in RAW264.7 cells. (H). Quantitative analysis of the MFI of CD86 depicted in G. (n = 3, mean ± s.d.). (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)
    Anti Cd86 Primary Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti cd86 primary antibody/product/Proteintech
    Average 96 stars, based on 1 article reviews
    anti cd86 primary antibody - by Bioz Stars, 2026-02
    96/100 stars
    		  Buy from Supplier
    primary antibodies include cd86  (Proteintech)
    96
    Proteintech primary antibodies include cd86
    ROS- s cavenging and a nti- i nflammatory p roperties of CVs. (A). CLSM images showing ROS green fluorescent levels in RAW264.7 cells with DCFH-DA probe. Scale bar, 50 μm. (B). Representative images of flow cytometry detecting ROS with various groups in RAW264.7 cells. (C). Quantitative analysis of the mean fluorescence intensity of ROS depicted in B. (n = 3, mean ± s.d.). (D). Representative images of flow cytometry detecting apoptosis rates of RAW264.7 cells in different groups. (E). Quantitative analysis of the MFI of apoptosis rates depicted in D. (n = 3, mean ± s.d.). (F). Representative immunofluorescence images of <t>CD86</t> in various groups. Scale bar, 50 μm. (G). Representative images of flow cytometry detecting CD86 with various groups in RAW264.7 cells. (H). Quantitative analysis of the MFI of CD86 depicted in G. (n = 3, mean ± s.d.). (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)
    Primary Antibodies Include Cd86, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibodies include cd86/product/Proteintech
    Average 96 stars, based on 1 article reviews
    primary antibodies include cd86 - by Bioz Stars, 2026-02
    96/100 stars
    		  Buy from Supplier
    primary antibodies against cd86  (Proteintech)
    96
    Proteintech primary antibodies against cd86
    ROS- s cavenging and a nti- i nflammatory p roperties of CVs. (A). CLSM images showing ROS green fluorescent levels in RAW264.7 cells with DCFH-DA probe. Scale bar, 50 μm. (B). Representative images of flow cytometry detecting ROS with various groups in RAW264.7 cells. (C). Quantitative analysis of the mean fluorescence intensity of ROS depicted in B. (n = 3, mean ± s.d.). (D). Representative images of flow cytometry detecting apoptosis rates of RAW264.7 cells in different groups. (E). Quantitative analysis of the MFI of apoptosis rates depicted in D. (n = 3, mean ± s.d.). (F). Representative immunofluorescence images of <t>CD86</t> in various groups. Scale bar, 50 μm. (G). Representative images of flow cytometry detecting CD86 with various groups in RAW264.7 cells. (H). Quantitative analysis of the MFI of CD86 depicted in G. (n = 3, mean ± s.d.). (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)
    Primary Antibodies Against Cd86, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibodies against cd86/product/Proteintech
    Average 96 stars, based on 1 article reviews
    primary antibodies against cd86 - by Bioz Stars, 2026-02
    96/100 stars
    		  Buy from Supplier
    primary antibodies  (Bio-Rad)
    93
    Bio-Rad primary antibodies
    ROS- s cavenging and a nti- i nflammatory p roperties of CVs. (A). CLSM images showing ROS green fluorescent levels in RAW264.7 cells with DCFH-DA probe. Scale bar, 50 μm. (B). Representative images of flow cytometry detecting ROS with various groups in RAW264.7 cells. (C). Quantitative analysis of the mean fluorescence intensity of ROS depicted in B. (n = 3, mean ± s.d.). (D). Representative images of flow cytometry detecting apoptosis rates of RAW264.7 cells in different groups. (E). Quantitative analysis of the MFI of apoptosis rates depicted in D. (n = 3, mean ± s.d.). (F). Representative immunofluorescence images of <t>CD86</t> in various groups. Scale bar, 50 μm. (G). Representative images of flow cytometry detecting CD86 with various groups in RAW264.7 cells. (H). Quantitative analysis of the MFI of CD86 depicted in G. (n = 3, mean ± s.d.). (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)
    Primary Antibodies, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibodies/product/Bio-Rad
    Average 93 stars, based on 1 article reviews
    primary antibodies - by Bioz Stars, 2026-02
    93/100 stars
    		  Buy from Supplier
    cd86 bm4121 primary antibodies  (Boster Bio)
    94
    Boster Bio cd86 bm4121 primary antibodies
    ROS- s cavenging and a nti- i nflammatory p roperties of CVs. (A). CLSM images showing ROS green fluorescent levels in RAW264.7 cells with DCFH-DA probe. Scale bar, 50 μm. (B). Representative images of flow cytometry detecting ROS with various groups in RAW264.7 cells. (C). Quantitative analysis of the mean fluorescence intensity of ROS depicted in B. (n = 3, mean ± s.d.). (D). Representative images of flow cytometry detecting apoptosis rates of RAW264.7 cells in different groups. (E). Quantitative analysis of the MFI of apoptosis rates depicted in D. (n = 3, mean ± s.d.). (F). Representative immunofluorescence images of <t>CD86</t> in various groups. Scale bar, 50 μm. (G). Representative images of flow cytometry detecting CD86 with various groups in RAW264.7 cells. (H). Quantitative analysis of the MFI of CD86 depicted in G. (n = 3, mean ± s.d.). (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)
    Cd86 Bm4121 Primary Antibodies, supplied by Boster Bio, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd86 bm4121 primary antibodies/product/Boster Bio
    Average 94 stars, based on 1 article reviews
    cd86 bm4121 primary antibodies - by Bioz Stars, 2026-02
    94/100 stars
    		  Buy from Supplier
    cd86 polyclonal antibody  (Bioss)
    95
    Bioss cd86 polyclonal antibody
    ROS- s cavenging and a nti- i nflammatory p roperties of CVs. (A). CLSM images showing ROS green fluorescent levels in RAW264.7 cells with DCFH-DA probe. Scale bar, 50 μm. (B). Representative images of flow cytometry detecting ROS with various groups in RAW264.7 cells. (C). Quantitative analysis of the mean fluorescence intensity of ROS depicted in B. (n = 3, mean ± s.d.). (D). Representative images of flow cytometry detecting apoptosis rates of RAW264.7 cells in different groups. (E). Quantitative analysis of the MFI of apoptosis rates depicted in D. (n = 3, mean ± s.d.). (F). Representative immunofluorescence images of <t>CD86</t> in various groups. Scale bar, 50 μm. (G). Representative images of flow cytometry detecting CD86 with various groups in RAW264.7 cells. (H). Quantitative analysis of the MFI of CD86 depicted in G. (n = 3, mean ± s.d.). (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)
    Cd86 Polyclonal Antibody, supplied by Bioss, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd86 polyclonal antibody/product/Bioss
    Average 95 stars, based on 1 article reviews
    cd86 polyclonal antibody - by Bioz Stars, 2026-02
    95/100 stars
    		  Buy from Supplier

    Image Search Results


    The effects of patches on angiogenesis and inflammation in infarcted tissues 4 weeks post-MI. a) Immunofluorescence staining of α-smooth muscle actin (α-SMA, a vascular protein marker, green) and von Willebrand factor (vWF, an endothelial marker, red) of the infarct region in the MI, BMN-P, BMN-CP and CBMN-CP groups. b, c) Quantitative analysis of α-SMA (b) and vWF (c) in different groups based on fluorescent staining images (n = 4). d) Representative immunofluorescence staining of the infarct region in different groups for CD86 (green) and CD206 (red). e, f) Fluorescence intensity statistics of CD86 (e) and CD206 (f) in different groups based on fluorescent staining images (n = 4). Nuclei are stained blue with DAPI. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001.

    Journal: Bioactive Materials

    Article Title: A self-locking conductive cardiac patch for immediate electrical integration with infarcted rat myocardium

    doi: 10.1016/j.bioactmat.2025.10.045

    Figure Lengend Snippet: The effects of patches on angiogenesis and inflammation in infarcted tissues 4 weeks post-MI. a) Immunofluorescence staining of α-smooth muscle actin (α-SMA, a vascular protein marker, green) and von Willebrand factor (vWF, an endothelial marker, red) of the infarct region in the MI, BMN-P, BMN-CP and CBMN-CP groups. b, c) Quantitative analysis of α-SMA (b) and vWF (c) in different groups based on fluorescent staining images (n = 4). d) Representative immunofluorescence staining of the infarct region in different groups for CD86 (green) and CD206 (red). e, f) Fluorescence intensity statistics of CD86 (e) and CD206 (f) in different groups based on fluorescent staining images (n = 4). Nuclei are stained blue with DAPI. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001.

    Article Snippet: The tissue sections were then incubated with the following primary antibodies: rabbit Connexin 43 primary antibody (BOSTER, BA1727, 1:200, China), mouse α-actinin primary antibody (Abcam, AB9465, 1:200, UK), mouse α-SMA primary antibody (Wuhan Sanying, 67735-1-IG, 1:400, China), rabbit vWF primary antibody (Wuhan Sanying, 27186-1-AP, 1:300, China), mouse CD86 primary antibody (BOSTER, BA4121, 1:100, China) and rabbit CD206 primary antibody (Wuhan Sanying, 18704-1-AP, 1:400, China).

    Techniques: Immunofluorescence, Staining, Marker, Fluorescence

    ROS- s cavenging and a nti- i nflammatory p roperties of CVs. (A). CLSM images showing ROS green fluorescent levels in RAW264.7 cells with DCFH-DA probe. Scale bar, 50 μm. (B). Representative images of flow cytometry detecting ROS with various groups in RAW264.7 cells. (C). Quantitative analysis of the mean fluorescence intensity of ROS depicted in B. (n = 3, mean ± s.d.). (D). Representative images of flow cytometry detecting apoptosis rates of RAW264.7 cells in different groups. (E). Quantitative analysis of the MFI of apoptosis rates depicted in D. (n = 3, mean ± s.d.). (F). Representative immunofluorescence images of CD86 in various groups. Scale bar, 50 μm. (G). Representative images of flow cytometry detecting CD86 with various groups in RAW264.7 cells. (H). Quantitative analysis of the MFI of CD86 depicted in G. (n = 3, mean ± s.d.). (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)

    Journal: Materials Today Bio

    Article Title: Vitamin C–functionalized copper nanozymes for treating drug-resistant intracellular infections and hyperinflammation

    doi: 10.1016/j.mtbio.2025.102348

    Figure Lengend Snippet: ROS- s cavenging and a nti- i nflammatory p roperties of CVs. (A). CLSM images showing ROS green fluorescent levels in RAW264.7 cells with DCFH-DA probe. Scale bar, 50 μm. (B). Representative images of flow cytometry detecting ROS with various groups in RAW264.7 cells. (C). Quantitative analysis of the mean fluorescence intensity of ROS depicted in B. (n = 3, mean ± s.d.). (D). Representative images of flow cytometry detecting apoptosis rates of RAW264.7 cells in different groups. (E). Quantitative analysis of the MFI of apoptosis rates depicted in D. (n = 3, mean ± s.d.). (F). Representative immunofluorescence images of CD86 in various groups. Scale bar, 50 μm. (G). Representative images of flow cytometry detecting CD86 with various groups in RAW264.7 cells. (H). Quantitative analysis of the MFI of CD86 depicted in G. (n = 3, mean ± s.d.). (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)

    Article Snippet: CD86 was detected using an anti-CD86 primary antibody (Proteintech, China), while nuclei were counterstained with DAPI.

    Techniques: Flow Cytometry, Fluorescence, Immunofluorescence